Ori Hershkovitz has been with the Sphera Fund since 2006, and serves as managing partner and head of pharmaceutical research. From 2001–2006 he was with Leader & Co. Investment House, where he was Israel senior pharmaceutical equity analyst. Between 1998–2001 Hershkovitz was an equity analyst at Ilanot Batucha Investment House. Hershkovitz has a bachelor's degree in business administration and finance from Tel Aviv University.
"CTH is very early in the game with a very good and relatively derisked idea."
The Life Science Report with Ori Hershkovitz